Safe Fertility Group Public Company Limited (SAFE.BK)
- Previous Close
8.85 - Open
8.85 - Bid --
- Ask --
- Day's Range
8.85 - 8.90 - 52 Week Range
8.50 - 23.60 - Volume
22,900 - Avg. Volume
77,460 - Market Cap (intraday)
2.69B - Beta (5Y Monthly) --
- PE Ratio (TTM)
16.09 - EPS (TTM)
0.55 - Earnings Date --
- Forward Dividend & Yield 0.62 (7.01%)
- Ex-Dividend Date May 8, 2025
- 1y Target Est
10.86
Safe Fertility Group Public Company Limited, together with its subsidiaries, provides fertility medical center services in Thailand. The company offers in vitro fertilization, intrauterine insemination, egg freezing, and embryo transfer for women; and percutaneous epididymal sperm aspiration, testicular sperm extraction, testicular sperm aspiration, microsurgical epidymal sperm aspiration, magnetic activated cell sorting, and sperm analysis and freezing services for men. It also provides couple checkup, embryoscope plus, preimplantation genetic testing for aneuploidies, preimplantation genetic testing for monogenic disorders, and acupuncture for inner body balance. In addition, the company engages in the business of genetic diagnosis, embryos and fetuses, and various genetics laboratory services. Further, it operates beauty care, and skin and aesthetic businesses. Safe Fertility Group Public Company Limited was founded in 2007 and is headquartered in Bangkok, Thailand.
www.safefertilitycenter.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SAFE.BK
View MorePerformance Overview: SAFE.BK
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SAFE.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SAFE.BK
View MoreValuation Measures
Market Cap
2.69B
Enterprise Value
1.14B
Trailing P/E
16.09
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.24
Price/Book (mrq)
1.51
Enterprise Value/Revenue
1.37
Enterprise Value/EBITDA
4.07
Financial Highlights
Profitability and Income Statement
Profit Margin
20.13%
Return on Assets (ttm)
6.51%
Return on Equity (ttm)
9.54%
Revenue (ttm)
830.13M
Net Income Avi to Common (ttm)
167.09M
Diluted EPS (ttm)
0.55
Balance Sheet and Cash Flow
Total Cash (mrq)
1.67B
Total Debt/Equity (mrq)
3.93%
Levered Free Cash Flow (ttm)
146.75M